Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting
- 1 August 2017
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 13 (6) , 1869-1878
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Designer vaccine nanodiscs for personalized cancer immunotherapyNature Materials, 2016
- High-Density Lipoproteins: Nature’s Multifunctional NanoparticlesACS Nano, 2016
- Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical TrialJournal of the American Heart Association, 2015
- Multicellular Tumor Spheroids as a Model for Assessing Delivery of Oligonucleotides in Three DimensionsMolecular Therapy Nucleic Acids, 2014
- Scavenger Receptor B1 is a Potential Biomarker of Human Nasopharyngeal Carcinoma and Its Growth is Inhibited by HDL-mimetic NanoparticlesTheranostics, 2013
- Nanoscale Drug Delivery Systems for Enhanced Drug Penetration into Solid Tumors: Current Progress and OpportunitiesCritical Reviews in Biomedical Engineering, 2012
- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein NanoparticlesNeoplasia, 2011
- RGD peptide functionalized and reconstituted high‐density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probeThe FASEB Journal, 2010
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- An overview of reverse cholesterol transportAtherosclerosis, 1994